Machine learning unlocks personalized approach to early ovarian cancer detection

For over three decades, a highly accurate early diagnostic test for ovarian cancer has eluded physicians.

Cybin Announces Grant of European Patent Protecting its Proprietary Deuterated Programs | Psychedelic Invest

– European patent provides composition of matter and medical use protection for the Company’s proprietary deuterated psilocybin analog and deuterated DMT programs – – New

October 26, 2023

Merck pens pact with Pearl Bio for new biologics in cancer

Merck is teaming up with a Khosla Ventures-backed biotech in a package that could be worth as much as $1 billion to create new biologics

March 13, 2024

Tenofovir Alafenamide Remains the Most Effective Treatment for Chronic HBV

VIENNA — Tenofovir alafenamide (TAF; Biktarvy) continued to be highly effective for chronic hepatitis B virus (HBV) infection for up to 8 years, according to

June 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.